Innovation and Internationalization

Home < Innovation and Internationalization

Quality Management

International Quality Care for Health

At Qingdao Bahealpharma, quality is the foundation of everything we do. We have built a comprehensive quality management system that spans the entire drug production lifecycle, supported by internationally advanced production equipment, testing instruments, and cutting-edge technologies. Every step of our manufacturingprocess strictly complies with international pharmaceutical standards and regulatory requirements, ensuring continuous adherence to Good Manufacturing Practice (GMP) and delivering medicines of consistent quality, safety, and efficacy.

Guided by our mission to “optimize medical scenarios through technological innovation,” we are committed to enhancing drug accessibility and providing greater health value to patients. This commitment begins at the source—with stringent raw material screening—and extends through precise process control, thorough quality testing, and rigorous final review before release. Every medicine that reaches patients embodies our dedication to protecting and promoting human health.

Moving forward, Qingdao Bahealpharma will continue to be driven by technological innovation and focused on patient needs. We are dedicated to continually strengthening our capabilities and contributing to a healthier future for all.

International Quality System

We establish and continuously enhance a robust quality system grounded in international regulations and standards, including those set by the NMPA, FDA, ICH, WHO, PIC/S, and ISPE. Guided by the “Quality by Design” (QbD) philosophy, we integrate quality and compliance into every stage of development and production.

This commitment forms the core of our company-wide quality culture, where every team member is dedicated to upholding the highest standards. Through this disciplined approach, we ensure the effective and reliable operation of our international-grade quality management system.

Driven by technological innovation and focused on patient needs, we are dedicated to delivering medicines that meet global benchmarks of excellence, contributing to a healthier future for all.

Quality Compliance & Continuous Improvement

Since achieving our first zero-defect FDA inspection in 2016, we have consistently passed rigorous on-site audits conducted by regulatory authorities such as the NMPA and FDA, as well as multiple customer audits each year. Notably, our facilities again received zero-defect findings from the FDA in 2024, reaffirming our sustained commitment to the highest quality standards.

We maintain a proactive quality management system focused on risk control and continual enhancement, driven by regulatory compliance and customer feedback. This systematic approach to excellence has earned us consistent recognition from auditing experts and partners worldwide.